Thrombolytic treatment for in-hospital ischemic strokes in United States
- PMID: 25566339
- PMCID: PMC4280877
Thrombolytic treatment for in-hospital ischemic strokes in United States
Abstract
Background: Despite the recent emphasis on protocols for emergent triage and treatment of in-hospital acute ischemic stroke, there is little data on outcomes of patients receiving thrombolytics for in-hospital ischemic strokes. The objective of this study was to determine the rates of patients with in-hospital ischemic stroke treated with thrombolytics and to compare outcomes with patients treated on admission.
Methods: We analyzed an 8-year data (2002-2010) from the National Inpatient Survey. We identified patients who had in-hospital ischemic strokes (thrombolytic treatment after 1 day of hospitalization) and those treated on admission day. We compared demographics, clinical characteristics, in hospital complications and procedures, length of stay, hospitalization charges, and discharge disposition between the two groups.
Results: A total of 25193 (19%) and 109784 (81%) patients received thrombolytics for in-hospital and on admission acute strokes, respectively. In-hospital complications including intracerebral hemorrhage, pneumonia, deep venous thrombosis, pulmonary embolism and sepsis and in-hospital procedures such as cerebral angiography, endovascular thrombectomy, carotid artery stent placement, carotid endarterectomy, intubation, mechanical ventilation, gastrostomy, transfusion of blood products were significantly higher in the in-hospital stroke group. In a multivariate analysis, those who were treated following in-hospital stroke had higher rates of in-hospital mortality (odds ratio (OR) 1.1, 95% confidence interval (CI) 1.0-1.3, p = 0.05), and post-thrombolytic ICH (OR 1.2, CI 1.0-1.3, p = 0.03).
Conclusion: One out of every five acute ischemic stroke patients treated with thrombolytics is receiving the treatment for in-hospital stroke. The higher mortality and complicated hospitalization in such patients needs to be recognized.
Keywords: Acute stroke; in-hospital stroke; stroke complications; stroke treatment; thrombolysis; thrombolytic treatment.
Similar articles
-
Outcomes of thrombolytic treatment for acute ischemic stroke in dialysis-dependent patients in the United States.J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e354-9. doi: 10.1016/j.jstrokecerebrovasdis.2013.03.016. Epub 2013 Apr 28. J Stroke Cerebrovasc Dis. 2013. PMID: 23635922
-
Impact of transfer status on hospitalization cost and discharge disposition for acute ischemic stroke across the US.J Neurosurg. 2016 May;124(5):1228-37. doi: 10.3171/2015.4.JNS141631. Epub 2015 Oct 9. J Neurosurg. 2016. PMID: 26452123
-
Effect of weekend compared with weekday stroke admission on thrombolytic use, in-hospital mortality, discharge disposition, hospital charges, and length of stay in the Nationwide Inpatient Sample Database, 2002 to 2007.Stroke. 2010 Oct;41(10):2323-8. doi: 10.1161/STROKEAHA.110.591081. Epub 2010 Aug 19. Stroke. 2010. PMID: 20724715
-
Endovascular Treatment of Thrombosis and Embolism.Adv Exp Med Biol. 2017;906:195-213. doi: 10.1007/5584_2016_116. Adv Exp Med Biol. 2017. PMID: 27664152 Review.
-
Endovascular Treatment of Acute Ischemic Stroke Due to Tandem Occlusions: Large Multicenter Series and Systematic Review.Cerebrovasc Dis. 2016;41(5-6):306-12. doi: 10.1159/000444069. Epub 2016 Feb 17. Cerebrovasc Dis. 2016. PMID: 26881779 Review.
Cited by
-
Comparing characteristics and outcomes of in-hospital stroke and community-onset stroke.J Neurol. 2022 Oct;269(10):5617-5627. doi: 10.1007/s00415-022-11244-2. Epub 2022 Jul 2. J Neurol. 2022. PMID: 35780193
-
In-Hospital Mechanical Thrombectomy: A Case Report.Case Rep Neurol. 2020 Dec 14;12(Suppl 1):22-26. doi: 10.1159/000501001. eCollection 2020 Sep-Dec. Case Rep Neurol. 2020. PMID: 33505268 Free PMC article.
-
Other Hospital-onset Acute Ischemic Stroke Due to Large Vessel Occlusion Treated by Mechanical Thrombectomy after Inter-hospital Transfer.Neurol Med Chir (Tokyo). 2020 Apr 15;60(4):209-216. doi: 10.2176/nmc.oa.2019-0261. Epub 2020 Mar 5. Neurol Med Chir (Tokyo). 2020. PMID: 32132345 Free PMC article.
-
Neuroprotective Effects and Mechanisms of Zhenlong Xingnao Capsule in In Vivo and In Vitro Models of Hypoxia.Front Pharmacol. 2019 Sep 26;10:1096. doi: 10.3389/fphar.2019.01096. eCollection 2019. Front Pharmacol. 2019. PMID: 31611791 Free PMC article.
References
-
- Vera R, Lago A, Fuentes B, Gallego J, Tejada J, Casado I, et al. In-hospital stroke: a multi-centre prospective registry. European Journal of Neurology: The official journal of the European Federation of Neurological Societies. 2011;18:170–6. - PubMed
-
- Park HJ, Cho HJ, Kim YD, Lee DW, Choi HY, Kim SM, et al. Comparison of the characteristics for in-hospital and out-of-hospital ischaemic strokes. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies. 2009;16:582–8. - PubMed
-
- Blacker DJ. In-hospital stroke. Lancet Neurology. 2003;2:741–6. - PubMed
-
- Farooq MU, Reeves MJ, Gargano J, Wehner S, Hickenbottom S, Majid A. In-hospital stroke in a statewide stroke registry. Cerebrovasc Dis. 2008;25:12–20. - PubMed
-
- Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg PJ, Kaste M. Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology. 2012;79:306–13. - PubMed
LinkOut - more resources
Full Text Sources